Actinium Pharmaceuticals Inc. buy BiotechBee
Start price
31.10.22
/
60%
€10.47
Target price
31.12.24
€18.00
Performance (%)
19.77%
End price
31.10.22
€12.54
Summary
This prediction ended on 31.10.22 with a price of €12.54. The prediction had a final performance of 19.77%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Actinium Pharmaceuticals Inc. | -11.801% | -11.801% | -74.114% |
iShares Core DAX® | -3.429% | 3.133% | 15.455% |
iShares Nasdaq 100 | -6.121% | -1.433% | 16.794% |
iShares Nikkei 225® | -7.364% | 1.018% | 8.293% |
iShares S&P 500 | -4.366% | 0.247% | 18.541% |
According to BiotechBee what are the pros and cons of Actinium Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Actinium Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 18,0
In the thread Trading Actinium Pharmaceuticals Inc.
Buy beendet
Stopped prediction by BiotechBee for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.84
04.02.24
04.02.24
€7.00
31.10.25
31.10.25
-66.38%
19.08.24
19.08.24
Could be very worthwhile Investment >20% year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.30
10.12.23
10.12.23
€6.00
31.05.25
31.05.25
-8.68%
04.02.24
04.02.24
Could be very worthwhile Investment >20% year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
06.02.23
06.02.23
€20.00
31.12.25
31.12.25
-29.20%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year